CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby announces that the Company has been approved for listing at Spotlight Stock Market.
The approval is given under the condition that CS MEDICA, a Danish medico cannabis company, raises the minimum limit in the Company’s forthcoming issue of units and that the Company obtains a sufficient number of shareholders, in accordance with Spotlight Stock Market’s regulations. Further, CS MEDICA today publishes the prospectus for the upcoming issue of units (shares and free of charge warrants), which amounts to a total of approx. DKK 33.1 million. The subscription period in the issue of units starts on August 17th and ends on August 31st, 2021. The Company has received subscription commitments of approx. DKK 13.4 million, corresponding to approx. 60 percent of the initial issue volume. The prospectus is available on the Company’s (www.cs-medica.com), Sedermera Fondkommission’s (www.sedermera.se), and Spotlight Stock Market’s (www.spotlightstockmarket.com) respective websites. The teaser will also be made available on the websites above at the start of the subscription period. Subscriptions are made to the bank/manager by following the bank’s/manager’s routines and guidelines.
